• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Enrico Repetto, MD

Latest:

Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes

Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.


Margaret I. Liang, MD, MS

Latest:

Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients

Among a cohort of insured patients with cancer, the median total monthly cost of oral lenvatinib was $17,253, and 75% of patients paid $100 or less out of pocket per month for the drug.


Jill Feldman

Latest:

Adverse Effect Management in the COCOON Trial for EGFR-Mutated NSCLC: Jill Feldman

Jill Feldman, cofounder and president, EGFR Resisters, shares the importance of being proactive in managing dermatologic toxicities in epidermal growth factor receptor (EGFR)–positive lung cancer.


Parul Mistry, MD, MA

Latest:

Predicting Opioid Use Disorder and Associated Risk Factors in a Medicaid Managed Care Population

A Medicaid managed care organization developed a machine learning model to identify opioid use disorder (OUD) risk factors and predict OUD incidence in its multistate population.


Lindsay Dymowski

Latest:

Contributor: How Pharmacists and Providers Can Improve Patient Care

Pharmacists and pharmacies can be doing more to help with medication management for their patients.


Dr Matthew Matasar | Image Credit: Rutgers Cancer Institute
Matthew Matasar, MD

Latest:

Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress

At the 30th European Hematology Association (EHA) Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.


Rachel Henderson, PharmD, BCPS

Latest:

Telehealth Intervention by Pharmacists Collaboratively Enhances Hypertension Management and Outcomes

Patient interaction and enhanced support with clinical pharmacists significantly improved pass rates for a measure of controlling blood pressure compared with usual care.



Jonathan T. Rawlins, MA

Latest:

Improving Pain Clinic Outcomes With Preappointment Surveys: Data-Driven Policy Change

Implementing a policy change to require preappointment surveys before scheduling initial clinic evaluations can improve wait-list times and show rates.


Deborah R. Kaye, MD, MS

Latest:

Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs

The authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.


Andrew D. Schreiner, MD, MSCR

Latest:

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

In this study, authors assessed the proportion of patients with nonalcoholic fatty liver disease (NAFLD) receiving prescriptions for statins in primary care.


James Motyka, PharmD

Latest:

Unintended Consequences of the Inflation Reduction Act: Clinical Development Toward Subsequent Indications

The Inflation Reduction Act will likely change incentives surrounding single-indication launches and postapproval research for additional indications in small molecule drugs, affecting patient access.


Sunny C. Lin, PhD, MS

Latest:

Bundled Payments Lead to Quality Improvements in Hospitals’ Skilled Nursing Facility Referral Networks

The Bundled Payments for Care Improvement program was associated with improved quality of skilled nursing facilities in hospital referral networks for patients undergoing surgery for joint replacement.


Anay Patel, MBA, MHA

Latest:

Linking Insured Adults to Behavioral Health Care: A Cost-Saving Solution

Connecting primary care providers and commercially insured adults to outpatient behavioral health services via a digital platform improved health outcomes and reduced medical costs.


Arshad Rahim, MD, MBA

Latest:

Stakeholder Insights on rtCGM in T2D Population Health Management

Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.


Carolina Schinke, MD

Latest:

Trispecifics in Context: Hype vs Readiness

A panelist emphasizes that while trispecific antibodies offer near-perfect response rates and convenient monthly dosing that could improve quality of life, careful assessment of adverse effects like infections and taste disturbances is crucial—especially for lower-risk patients—making patient preference and physician judgment key in determining their optimal use, with high-risk patients with heavily pretreated disease poised to benefit most.


John Allan, MD

Latest:

Final Thoughts on Bispecifics in B-Cell Lymphomas From ASH 2024

Panelists share their final thoughts on bispecific therapies in B-cell lymphomas based on insights from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition 2024.



Sharon L. R. Kardia, PhD

Latest:

Building Trust: Public Priorities for Health Care AI Labeling

A Michigan-based deliberative study found strong public support for patient-informed artificial intelligence (AI) labeling in health care, emphasizing transparency, privacy, equity, and safety to build trust.


Micaela Mercado, PhD, LMSW

Latest:

Implementation of the Accountable Health Communities Model in Arizona

The Accountable Health Communities Model facilitates multisector coordination. Implementation science elucidated the contextual factors that facilitated the use of this model in Arizona.


Emmanuel F. Drabo, PhD

Latest:

A Health Economic Evaluation of Digital Digestive Care Management

Chronic gastrointestinal disorders are common and costly for employers. Use of a digital digestive care program was associated with reduced health care spending.


Soo Borson, MD

Latest:

Utilization of Low- and High-Value Health Care by Individuals With and Without Cognitive Impairment

Low-value service utilization is common among all older adults, and utilization of some high-value services decreases after the onset of cognitive decline.


Richard Freeman, MD

Latest:

Successes and Failures With Bundled Payments in the Commercial Market

The relatively few examples of commercially funded condition-specific bundled payments provide insights into how to spread this alternative payment model further in the private insurance market.


Karen O. Moss, PhD, RN, CNL

Latest:

Integrating Primary Care and Public Health for Advance Care Planning

This article proposes a new model, Public-Primary ACP, that leverages coordination between primary care and public health workforces to improve delivery of advance care planning.


Kathryn Brignole, MSc

Latest:

Pervasiveness and Clinical Staff Perceptions of HPV Vaccination Feedback

This article used regression analyses to quantify how clinical staff perceive provider feedback to improve human papillomavirus (HPV) vaccination rates and determine the prevalence of such feedback.


Anuraag R. Kansal, PhD

Latest:

Cost-Effectiveness of a Multicancer Early Detection Test in the US

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.


Shishir Maharjan, MS

Latest:

Continuity of Opioid Prescribing Among Older Adults on Long-term Opioids

Among older adults with chronic noncancer pain on long-term opioid therapy, greater continuity of opioid prescribing was significantly associated with fewer opioid-related adverse outcomes.


Dr Andrew S. Oseran | Image Credit: Beth Israel Deaconess Medical Center
Andrew S. Oseran, MD, MBA, MSc

Latest:

Further Research Into Medicare Advantage Upcoding, Documentation Accuracy Needed

Andrew S. Oseran, MD, MBA, MSc, hypothesizes that higher Medicare Advantage (MA) risk scores may result from either a more accurate capture of beneficiaries' comorbidities or inappropriate "upcoding" of conditions.


Nynikka R. Palmer, DrPH, MPH

Latest:

“Can You Hear Me Now?”: Postoperative Patient-Initiated Communication With Providers

Patient-provider communication after surgery is critical for patient safety. The growth of patient-provider communication technologies has created opportunities to study postoperative patient-initiated communication.


Selen Bozkurt, PhD

Latest:

Characterizing Patient Flow After an Academic Hospital Merger and Acquisition

This study assessed health care utilization and patient flow after a recent merger of community practices, a community hospital, and an academic medical center.

© 2026 MJH Life Sciences
AJMC®
All rights reserved.